(Q48895801)

English

Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.

scientific article published in January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain. (English)

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

0 references

1 reference

based on heuristic

inferred from title

Wolfgang H Sommer

2

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

3

object named as

Fuxe K

1 reference

Europe PubMed Central

16 February 2018

author name string

Khan A

1

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

Akhtar S

4

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

publication date

1 January 2000

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

Journal of Drug Targeting

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

8

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

319-334

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

In vivo studies with antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

The application of antisense oligonucleotide technology to the brain: some pitfalls

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Intra-amygdala infusion of an end-capped antisense oligodeoxynucleotide to c-fos accelerates amygdala kindling.

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Antisense oligonucleotides to the GluR2 AMPA receptor subunit modify excitatory synaptic transmission in vivo

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Intrastriatal and intraventricular injections of oligodeoxynucleotides in the rat brain: tissue penetration, intracellular distribution and c-fos antisense effects.

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Biodegradable microspheres in drug delivery

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Antisense inhibition of striatal GABAA receptor proteins decreases GABA-stimulated chloride uptake and increases cocaine sensitivity in rats

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal gamma-aminobutyric acid transmission in the conscious rat.

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Pharmacokinetics of antisense analogues in the central nervous system

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Antisense oligonucleotide strategies in neuropharmacology

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Uptake and distribution of fluorescein-labeled D2 dopamine receptor antisense oligodeoxynucleotide in mouse brain

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine

1 reference

https://api.crossref.org/works/10.3109%2F10611860008997909

21 January 2018

Identifiers

10.3109/10611860008997909

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/11328659

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48895801&oldid=1769949297"